Global Insulin Market – Share, Growth, Regions, Drivers and Forecast to 2018-2025 - PowerPoint PPT Presentation

About This Presentation

Global Insulin Market – Share, Growth, Regions, Drivers and Forecast to 2018-2025

Description: just released a new market research report focusing on the “Insulin Market with Global analysis and forecasts until 2025” to its database. – PowerPoint PPT presentation

Number of Views:32


Transcript and Presenter's Notes

Title: Global Insulin Market – Share, Growth, Regions, Drivers and Forecast to 2018-2025

Global Insulin Market
  • Drivers, Restraints, Potential Growth
    Opportunities, Product Size, Application
    Estimation, Vendor Competitive Landscape, Trends
    and Forecast 2018-2025

Single Use License US 3600
Request Sample
Global Insulin Market Share Analysis, Trends
  • The global insulin market size was evaluated to
    be xx billion in 2016. It is supposed to grow
    at a compound annual growth rate of xx during
    the forecast period, reaching a value of xx
    billion by the year 2025. Key global markets for
    insulin are significantly moving forward owing to
    several significant patent protection by brands,
    continuously updated medical reimbursement
    guidelines for treatment by the government, and
    an extensively well-established distribution
  • Insulin is a hormone secreted by the pancreatic
    beta cells, which helps control the metabolism of
    carbohydrates, fats, and proteins. It is
    responsible for the conversion of glucose from
    the consumed food into energy, or store glucose
    for further use. It keeps the blood sugar level
    from getting too low or too high. The global
    insulin market is experiencing a rapid growth
    because it is used to treat Type 1 and Type 2
    diabetes. Very common in todays world, diabetes
    is a disease in which the body is unable to
    produce or respond to the insulin hormone, which
    results in abnormal levels of glucose in the
    blood. Synthetic insulin was developed for this
    purpose in the 1960s and 1970s, and it first got
    approved for pharmaceutical use in 1982. It has
    the same characteristic as natural insulin. It is
    of four types rapid-acting, short-acting,
    intermediate-acting, and long-acting, depending
    on the time it takes for the drug to activate in
    the body and the duration for which it stays

Global Insulin Market Share Analysis, Trends
  • There are three ways in which insulin can be
    administered to a patient. Syringe is the most
    commonly used device, which is made of plastic
    and is disposable. Insulin pen is a popular
    alternative to the syringe. It consists of a
    cartridge (containing the drug) and a needle,
    which are easily replaceable. It has a mechanical
    pump, which can be monitored to release insulin
    in the body. Lastly, insulin pumps are used by
    patients who require short-acting insulin
    throughout the day. The global insulin market is
    responsible for manufacturing both the drug and
    the devices used to deliver the drug.
  • Browse the complete report on _at_

Global Insulin Market Share Analysis, Trends
  • The major factor boosting the growth of the
    insulin market size is an increasing number of
    cases of diabetes arising due to a rise in the
    geriatric population, and popularization of
    unhealthy lifestyle and eating habits, which
    leads to obesity. Diabetes is a major public
    health threat for the world. The insulin industry
    has significant potential for growth in values
    because of increased investment in the research
    and development of more effective insulin. It is
    very important for controlling diabetes as it is
    a progressive condition, which may get worse with
    time. However, the approval procedure for insulin
    is very strict. The high cost of insulin analog
    also inhibits the growth of the insulin market
  • North America has the largest share in the global
    insulin market, and it will continue the same
    trend during the forecast period. It is closely
    followed by Europe. However, the Asia Pacific
    region is the fastest growing market for insulin.
    In a study done in 2012, it was found that around
    60 of the Asian population has diabetes. China
    is expected to have the highest prevalence rate
    of diabetes, followed by India. Some of the key
    players in the insulin manufacturing industry are
    Novo Nordisk (Denmark), Sanofi S.A. (France, Eli
    Lilly Company (US), Wockhardt Ltd. (India) and
    Bioton S.A (Poland).
  • Purchase a single user copy of the global insulin
    market report_at_ https//

About Us
  • Adroit Market Research is an India-based business
    analytics and consulting company. Our target
    audience is a wide range of corporations,
    manufacturing companies, product/technology
    development institutions and industry
    associations that require understanding of a
    markets size, key trends, participants and
    future outlook of an industry. We intend to
    become our clients knowledge partner and provide
    them with valuable market insights to help create
    opportunities that increase their revenues. We
    follow a code Explore, Learn and Transform. At
    our core, we are curious people who love to
    identify and understand industry patterns, create
    an insightful study around our findings and churn
    out money-making roadmaps. Our analysts have
    tracked high growth markets in chemicals
    materials, healthcare pharmaceuticals,
    semiconductor electronics, energy power, food
    retail, consumer goods, technology, and
    machinery equipment sectors across the world to
    identify new opportunities, potential customers,
    prepare go-to-market (GTM) strategies, identify
    segments for revenue growth for companies, and
    many more.
  • US Headquarters3131 McKinney Ave Ste 600
    Dallas, TX 75204 ,U.S.A 
  • Phone 1 (214) 884-6068
  • Email
Write a Comment
User Comments (0)